Company Analysis Ono Pharmaceutical Co., Ltd.
1. Summary
Advantages
- Price (3.66 $) is less than fair price (5.16 $)
- The company's current efficiency (ROE=16.68%) is higher than the sector average (ROE=13.16%)
Disadvantages
- Dividends (0%) are below the sector average (1.73%).
- The stock's return over the last year (-32.94%) is lower than the sector average (-4.97%).
- Current debt level 0.9699% has increased over 5 years from 0.3358%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Ono Pharmaceutical Co., Ltd. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 10.2% | -6% | -2.6% |
| 90 days | -1.9% | -1.3% | -4.7% |
| 1 year | -32.9% | -5% | 12.9% |
OPHLY vs Sector: Ono Pharmaceutical Co., Ltd. has significantly underperformed the "Healthcare" sector by -27.97% over the past year.
OPHLY vs Market: Ono Pharmaceutical Co., Ltd. has significantly underperformed the market by -45.88% over the past year.
Stable price: OPHLY is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: OPHLY with weekly volatility of -0.6335% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (3.66 $) is lower than the fair price (5.16 $).
Price significantly below the fair price: The current price (3.66 $) is 41% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (3.12) is lower than that of the sector as a whole (31.91).
P/E vs Market: The company's P/E (3.12) is lower than that of the market as a whole (51.38).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.5003) is lower than that of the sector as a whole (3.26).
P/BV vs Market: The company's P/BV (0.5003) is higher than that of the market as a whole (-9.02).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0.7949) is lower than that of the sector as a whole (3.22).
P/S vs Market: The company's P/S indicator (0.7949) is lower than that of the market as a whole (4.71).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (1.36) is lower than that of the sector as a whole (10.21).
EV/Ebitda vs Market: The company's EV/Ebitda (1.36) is lower than that of the market as a whole (27.8).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 22.87% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (22.87%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-44.01%).
5.4. ROE
ROE vs Sector: The company's ROE (16.68%) is higher than that of the sector as a whole (13.16%).
ROE vs Market: The company's ROE (16.68%) is higher than that of the market as a whole (5.09%).
5.5. ROA
ROA vs Sector: The company's ROA (14.25%) is higher than that of the sector as a whole (6.08%).
ROA vs Market: The company's ROA (14.25%) is lower than that of the market as a whole (16.55%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (19.96%) is higher than that of the sector as a whole (15.56%).
ROIC vs Market: The company's ROIC (19.96%) is higher than that of the market as a whole (11.03%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.73%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0% has been steadily paid over the past 7 years, DSI=0.79.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 1 year.
7.3. Payout percentage
Dividend Coverage: Current payments from income (29.05%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
